Atlas Trials

Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19

Clinical trial NCT04338360 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT04338360
Sponsor
Mayo Clinic
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
COVID19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.